Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST

benzinga.com MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. ("Ocugen" or the "Company") OCGN, a biotechnology company focused on discovering, developing, and commercializing…

OCGN Stock Earnings: Ocugen Beats EPS for Q1 2024

investorplace.com Ocugen (NASDAQ: ) just reported results for the first quarter of 2024. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of…

Ocugen Provides Business Update with First Quarter 2024 Financial Results

benzinga.com All three first-in-class modifier gene therapy product candidates currently in the clinic with OCU400 Phase 3 in progress OCU400 on track to meet 2026 Biologics License…

Options Volatility and Implied Earnings Moves Today, May 14, 2024

tipranks.com Today, several major companies are expected to report earnings: Home Depot (HD), Vodafone (VOD), Alibaba (BABA), Ocugen (OCGN), Asensus Surgical (A...

Ocugen to Present at May 2024 Investor Conferences

benzinga.com MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. ("Ocugen" or the "Company") OCGN, a biotechnology company focused on discovering, developing, and commercializing…

Millionaire Blueprint: 3 Stocks Under $5 With Massive Growth Potential by 2028

investorplace.com Seize hidden opportunities with three undervalued stocks poised for substantial growth in diverse industries Opportunities can lurk in plain sight in the ever-changing stock…

Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results

benzinga.com MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) OCGN, a biotechnology company focused on discovering, developing, and commercializing…